EUVIMEDEUVIMED entdecken
Crossref

Depalmitoylation regulates metabolism and mitochondrial function

Sarah L. Speck

Open Scholarship Institutional Repository (Washington University in St. Louis) · 07.07.2025

DOI: 10.7936/awsp-nn17 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Scholarship Institutional Repository (Washington University in St. Louis), erschienen am 07.07.2025. Verfasst von Sarah L. Speck.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tens of millions of Americans suffer from metabolic disorders, predisposing patients to cardiovascular disease, kidney disease, liver disease, infertility, and cancer. Unfortunately, the etiology of many of these diseases remains a mystery, limiting our ability to identify targets for pharmacologic therapies. Due to the relationship between altered lipid dynamics and metabolic dysfunction, we decided to study the effect of the posttranslational lipid modification, S-palmitoylation, on metabolism. S-palmitoylation is the only known reversible lipid modification for proteins, and this depalmitoylation process is catalyzed by acyl-protein thioesterases including APT1 and APT2. We hypothesized that APT deficiency in various tissues would predispose mammals to metabolic disease. We generated mice with APT deficiency in endothelial cells, pancreatic beta cells, or the liver. We found that endothelial APT1 deficiency impaired recovery of perfusion in a mouse model of peripheral artery disease. Next, we discovered that APT1-deficient beta cells hypersecrete insulin, which leads to early beta cell failure in genetic and dietary models of type 2 diabetes. We then determined that hepatic APT1 and APT2 regulate insulin sensitivity and glutamine-induced gluconeogenesis, as well as mitochondrial respiration. In each of these studies, we identified several novel APT substrates, as well as new pathways for upstream regulation of APT activity. These findings establish depalmitoylases as critical mediators of metabolic signaling and potential targets for novel therapies.

Schlagwörter

depalmitoylationS-palmitoylationacyl protein thioesterasesAPT1metabolic disordersperipheral arterial diseaseendothelial cellsbeta-cell failuretype 2 diabetesinsulin hypersecretion

Zitieren

APA

Speck, S. L. (2025). Depalmitoylation regulates metabolism and mitochondrial function. Open Scholarship Institutional Repository (Washington University in St. Louis). https://doi.org/10.7936/awsp-nn17

Vancouver

Speck SL. Depalmitoylation regulates metabolism and mitochondrial function. Open Scholarship Institutional Repository (Washington University in St. Louis). 2025. doi:10.7936/awsp-nn17

BibTeX
@article{Speck2025,
  author = {Speck, Sarah L.},
  title = {Depalmitoylation regulates metabolism and mitochondrial function},
  journal = {Open Scholarship Institutional Repository (Washington University in St. Louis)},
  year = {2025},
  doi = {10.7936/awsp-nn17}
}
Kostenlos starten →